"Narrative Summit" Releases 2025 Recommendations to Cement Egypt's Position as a Global Tourism Destination    Egypt, S.Arabia step up trade ties through coordination council talks    Egypt reviews progress on $200m World Bank-funded waste management hub    Egypt urges Israel to accept Gaza deal amid intensifying fighting    Egypt, ADIB explore strategic partnership in digital healthcare, investment    SCZONE, Tokyo Metropolitan Government sign MoU on green hydrogen cooperation    Egypt welcomes international efforts for peace in Ukraine    Al-Sisi, Macron reaffirm strategic partnership, coordinate on Gaza crisis    Contact Reports Strong 1H-2025 on Financing, Insurance Gains    Egypt, India's BDR Group in talks to establish biologics, cancer drug facility    AUC graduates first cohort of film industry business certificate    Egyptian pound down vs. US dollar at Monday's close – CBE    Egypt's FM, Palestinian PM visit Rafah crossing to review Gaza aid    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt recovers collection of ancient artefacts from Netherlands    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Egypt, Namibia explore closer pharmaceutical cooperation    Fitch Ratings: ASEAN Islamic finance set to surpass $1t by 2026-end    Renowned Egyptian novelist Sonallah Ibrahim dies at 88    Egyptian, Ugandan Presidents open business forum to boost trade    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt, Huawei explore healthcare digital transformation cooperation    Egypt's Sisi, Sudan's Idris discuss strategic ties, stability    Egypt to inaugurate Grand Egyptian Museum on 1 November    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Ibnsina Pharma's net revenues increase 39% y-o-y to EGP 13.3bn in 2018
Published in Daily News Egypt on 10 - 03 - 2019

Ibnsina Pharma, Egypt's fastest-growing and the second-largest pharmaceutical distributor, succeeded in increasing its net revenues by 39% year-on-year (y-o-y) to reach EGP 13.3bn, in 2018, according to the company's audited results which were announced on Sunday.
Ibnsina's gross profit for the period grew by 36% y-o-y to reach EGP 1.1bn in 2018, yielding a gross profit margin of 8.4%. while the company's operating profit grew 59.4% y-o-y to record EGP 412.7m during the same period.
Moreover, earnings before interest, tax, depreciation and amortisation (EBITDA) grew at a rapid 49.6% y-o-y, recording EGP 573.9m for 2018, yielding an EBITDA margin of 4.3%.
Accordingly, Ibnsina's net profit recorded EGP 262.5m, marking an increase by 50% y-o-y, despite one-off charges of EGP 59.7m incurred during the period.
On quarterly basis, Ibnsina Pharma's revenues grew 35.5% y-o-y to EGP 3.9bn, while the gross profit stood at EGP 316.5m in the last quarter (Q4) of 2018, growing 38.4% year-on-year and yielding a margin of 8.1%.
Ibnsina's operating profit grew at a rapid 42.3% y-o-y during the period to record EGP 118.8m, representing an operating profit margin of 3.1%.
While EBITDA recorded a significant 50.5% increased y-o-y to record EGP 167.2m during the quarter, with EBITDA margin standing at 4.3%. Net profit recorded EGP 74.2m in Q4 of 2018, growing at a remarkable 172.8% y-o-y to yield a net profit margin of 1.9%.


Clic here to read the story from its source.